{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T01:15:07Z","timestamp":1785806107569,"version":"3.56.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T00:00:00Z","timestamp":1586736000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004381","name":"Western University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004381","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.nbd.2020.104872","type":"journal-article","created":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T19:41:11Z","timestamp":1586893271000},"page":"104872","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Expanding the search for genetic biomarkers of Parkinson's disease into the living brain"],"prefix":"10.1016","volume":"140","author":[{"given":"Simon M.","family":"Benoit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5366-8061","authenticated-orcid":false,"given":"Susanne","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roumiana","family":"Alexandrova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaganjot","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhooma","family":"Thiruvahindrapuram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio L.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandar","family":"Jog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew O.","family":"Hebb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2020.104872_bb0005","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.cellsig.2010.10.020","article-title":"Apoptosis in Parkinson\u2019s disease: is p53 the missing link between genetic and sporadic Parkinsonism?","volume":"23","author":"Alves da Costa","year":"2011","journal-title":"Cell. Signal."},{"key":"10.1016\/j.nbd.2020.104872_bb0010","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1038\/nprot.2013.099","article-title":"Count-based differential expression analysis of RNA sequencing data using R and Bioconductor","volume":"8","author":"Anders","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.nbd.2020.104872_bb0015","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/cns.13082","article-title":"Amyloid beta soluble forms and plasminogen activation system in Alzheimer\u2019s disease: consequences on extracellular maturation of brain-derived neurotrophic factor and therapeutic implications","volume":"25","author":"Angelucci","year":"2019","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.nbd.2020.104872_bb0020","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s10534-018-0087-5","article-title":"The ferroportin-ceruloplasmin system and the mammalian iron homeostasis machine: regulatory pathways and the role of lactoferrin","volume":"31","author":"Bonaccorsi di Patti","year":"2018","journal-title":"BioMetals"},{"key":"10.1016\/j.nbd.2020.104872_bb0025","doi-asserted-by":"crossref","first-page":"9546","DOI":"10.1073\/pnas.0914005107","article-title":"Independent filtering increases detection power for high-throughput experiments","volume":"107","author":"Bourgon","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.nbd.2020.104872_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013861","article-title":"Levodopa-induced dyskinesia is associated with increased thyrotropin releasing hormone in the dorsal striatum of hemi-parkinsonian rats","volume":"5","author":"Cantuti-Castelvetri","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2020.104872_bb0035","first-page":"419","article-title":"Genetics of early onset stroke (GEOS) study","volume":"22","author":"Connell","year":"2014","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.nbd.2020.104872_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2199-9-46","article-title":"Identification of valid reference genes for the normalization of RT qPCR gene expression data in human brain tissue","volume":"9","author":"Coulson","year":"2008","journal-title":"BMC Mol. Biol."},{"key":"10.1016\/j.nbd.2020.104872_bb0045","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jmoldx.2011.01.010","article-title":"The effect of formaldehyde fixation on RNA: optimization of formaldehyde adduct removal","volume":"13","author":"David","year":"2011","journal-title":"J. Mol. Diagnostics"},{"key":"10.1016\/j.nbd.2020.104872_bb0050","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0021-9150(92)90014-8","article-title":"The status of PAI-1 as a risk factor for arterial and thrombotic disease: a review","volume":"95","author":"Dawson","year":"1992","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.nbd.2020.104872_bb0055","first-page":"1","article-title":"Integrative analyses of proteomics and RNA transcriptomics implicate mitochondrial processes, protein folding pathways and GWAS loci in Parkinson disease","volume":"9","author":"Dumitriu","year":"2016","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.nbd.2020.104872_bb0060","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00401-011-0828-9","article-title":"Expression analysis of dopaminergic neurons in Parkinson\u2019s disease and aging links transcriptional dysregulation of energy metabolism to cell death","volume":"122","author":"Elstner","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2020.104872_bb0065","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.neuropharm.2005.04.001","article-title":"Neuroprotective effects of novel small peptides in vitro and after brain injury","volume":"49","author":"Faden","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2020.104872_bb0070","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1214\/009053606000000425","article-title":"On the Benjamini-Hochberg method","volume":"34","author":"Ferreira","year":"2006","journal-title":"Ann. Stat."},{"key":"10.1016\/j.nbd.2020.104872_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-019-1412-9","article-title":"Neuroinflammation and fractalkine signaling in Alzheimer\u2019s disease","volume":"16","author":"Finneran","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.nbd.2020.104872_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/gb-2005-6-13-r112","article-title":"Systematic analysis of gene expression in human brains before and after death","volume":"6","author":"Franz","year":"2005","journal-title":"Genome Biol."},{"key":"10.1016\/j.nbd.2020.104872_bb0085","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1124\/jpet.102.044040","article-title":"The thyrotropin-releasing hormone (TRH) hypothesis of homeostatic regulation: implications for TRH-based therapeutics","volume":"305","author":"Gary","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2020.104872_bb0090","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.bbadis.2017.01.023","article-title":"Modulation of BDNF cleavage by plasminogen-activator inhibitor-1 contributes to Alzheimer\u2019s neuropathology and cognitive deficits","volume":"1863","author":"Gerenu","year":"2017","journal-title":"Biochim. Biophys. Acta - Mol. Basis Dis."},{"key":"10.1016\/j.nbd.2020.104872_bb0095","doi-asserted-by":"crossref","first-page":"6680","DOI":"10.1038\/sj.onc.1209954","article-title":"Introduction to NF-\u03baB: players, pathways, perspectives","volume":"25","author":"Gilmore","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.nbd.2020.104872_bb0100","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/mds.20213","article-title":"Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations","volume":"19","author":"Goetz","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2020.104872_bb0105","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.neurobiolaging.2018.01.021","article-title":"Transcriptional alterations in skin fibroblasts from Parkinson\u2019s disease patients with parkin mutations","volume":"65","author":"Gonz\u00e1lez-Casacuberta","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2020.104872_bb0110","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12883-015-0331-3","article-title":"Ceruloplasmin activity and iron chelation treatment of patients with Parkinson\u2019s disease","volume":"15","author":"Grolez","year":"2015","journal-title":"BMC Neurol."},{"key":"10.1016\/j.nbd.2020.104872_bb0115","doi-asserted-by":"crossref","DOI":"10.1001\/archneur.62.6.917","article-title":"Expression profiling of substantia Nigra in Parkinson disease, progressive Supranuclear palsy, and frontotemporal dementia with parkinsonism","volume":"62","author":"Hauser","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2020.104872_bb0120","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.parkreldis.2017.02.011","article-title":"Effects of intracerebral neurotrophic factor application on motor symptoms in Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"38","author":"Hegarty","year":"2017","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.nbd.2020.104872_bb0125","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000075","article-title":"Next-generation profiling to identify the molecular etiology of Parkinson dementia","volume":"2","author":"Henderson-Smith","year":"2016","journal-title":"Neurol. Genet."},{"key":"10.1016\/j.nbd.2020.104872_bb0130","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3233\/JPD-150737","article-title":"Transcriptomic profiling of extracellular RNAs present in cerebrospinal fluid identifies differentially expressed transcripts in Parkinson\u2019s disease","volume":"6","author":"Hossein-Nezhad","year":"2016","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.nbd.2020.104872_bb0135","article-title":"Parkinson\u2019s disease is related to an increased risk of ischemic stroke\u2014a population-based propensity score-matched follow-up study","volume":"8","author":"Huang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2020.104872_bb0140","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2020.104872_bb0145","doi-asserted-by":"crossref","first-page":"214.e1","DOI":"10.1016\/j.neurobiolaging.2015.10.026","article-title":"Comparative blood transcriptome analysis in idiopathic and LRRK2 G2019S-associated Parkinson\u2019s disease","volume":"38","author":"Infante","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2020.104872_bb0150","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.neurobiolaging.2014.10.039","article-title":"Identification of candidate genes for Parkinson\u2019s disease through blood transcriptome analysis in LRRK2-G2019S carriers, idiopathic cases, and controls","volume":"36","author":"Infante","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2020.104872_bb0155","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1212\/WNL.40.10.1529","article-title":"Variable expression of Parkinson\u2019s disease: a base-line analysis of the DAT ATOP cohort","volume":"40","author":"Jankovic","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2020.104872_bb0160","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.npep.2010.08.004","article-title":"Protective effects of TRH and its analogues against various cytotoxic agents in retinoic acid (RA)-differentiated human neuroblastoma SH-SY5Y cells","volume":"44","author":"Jaworska-Feil","year":"2010","journal-title":"Neuropeptides"},{"key":"10.1016\/j.nbd.2020.104872_bb0165","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s00702-015-1405-5","article-title":"Neuropathobiology of non-motor symptoms in Parkinson disease","volume":"122","author":"Jellinger","year":"2015","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.nbd.2020.104872_bb0170","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1159\/000116972","article-title":"Assessment of sudomotor dysfunction in early Parkinson\u2019s disease","volume":"33","author":"Kihara","year":"1993","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.nbd.2020.104872_bb0175","doi-asserted-by":"crossref","first-page":"24862","DOI":"10.1074\/jbc.M112.348128","article-title":"Proteolytic cleavage of extracellular \u03b1-synuclein by plasmin: implications for Parkinson disease","volume":"287","author":"Kim","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2020.104872_bb0180","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/mds.25344","article-title":"Trophic factor gene therapy for Parkinson\u2019s disease","volume":"28","author":"Kordower","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2020.104872_bb0185","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1182\/blood-2008-07-170787","article-title":"CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival","volume":"113","author":"Landsman","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.nbd.2020.104872_bb0190","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.brainres.2006.05.101","article-title":"Murine central and peripheral nervous system transcriptomes: comparative gene expression","volume":"1107","author":"LeDoux","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2020.104872_bb0195","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000116793","article-title":"TRH test and the continuous dopaminergic stimulation in complicated Parkinson\u2019s disease","volume":"32","author":"Lestingi","year":"1992","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.nbd.2020.104872_bb0200","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1017\/cjn.2018.56","article-title":"Stroke and coronary artery disease are associated with Parkinson\u2019s disease","volume":"45","author":"Li","year":"2018","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2020.104872_bb0205","first-page":"1","article-title":"Nitric oxide, Iron and neurodegeneration","volume":"13","author":"Liu","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.nbd.2020.104872_bb0210","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3233\/JAD-2004-6510","article-title":"Thyrotropin releasing hormone inhibits tau phosphorylation by dual signaling pathways in hippocampal neurons","volume":"6","author":"Luo","year":"2004","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2020.104872_bb0215","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/s41598-017-01402-2","article-title":"Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson\u2019s disease","volume":"7","author":"Martin-Bastida","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2020.104872_bb0220","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.celrep.2012.02.014","article-title":"IRF8 is a critical transcription factor for transforming microglia into a reactive phenotype","volume":"1","author":"Masuda","year":"2012","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2020.104872_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0146129","article-title":"Iron and oxidative stress in Parkinson\u2019s disease: an observational study of injury biomarkers","volume":"11","author":"Medeiros","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2020.104872_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10048-005-0020-2","article-title":"Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson\u2019s disease","volume":"7","author":"Moran","year":"2006","journal-title":"Neurogenetics"},{"key":"10.1016\/j.nbd.2020.104872_bb0235","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.nbd.2013.11.007","article-title":"Involvement of the immune system, endocytosis and EIF2 signaling in both genetically determined and sporadic forms of Parkinson\u2019s disease","volume":"63","author":"Mutez","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2020.104872_bb0240","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0022-510X(98)00150-6","article-title":"Sustained release dosage of thyrotropin-releasing hormone improves experimental Japanese encephalitis virus-induced parkinsonism in rats","volume":"159","author":"Ogata","year":"1998","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2020.104872_bb0245","first-page":"3","article-title":"Hypothalamic dysfunction in Parkinson\u2019s disease patients","volume":"50","author":"Otake","year":"1994","journal-title":"Acta Med. Hung."},{"key":"10.1016\/j.nbd.2020.104872_bb0250","first-page":"5517","article-title":"Role of plasminogen activator inhibitor-1 in the diagnosis and prognosis of patients with Parkinson\u2019s disease","volume":"15","author":"Pan","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.nbd.2020.104872_bb0255","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2013.10","article-title":"Cerebrospinal fluid biomarkers in Parkinson disease","volume":"9","author":"Parnetti","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.nbd.2020.104872_bb0260","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.clineuro.2011.05.014","article-title":"Prevalence of radiological and clinical cerebrovascular disease in idiopathic Parkinson\u2019s disease","volume":"113","author":"Patel","year":"2011","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.nbd.2020.104872_bb0265","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/ejn.14102","article-title":"Trophic factors for Parkinson\u2019s disease: where are we and where do we go from here?","volume":"49","author":"Paul","year":"2019","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2020.104872_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0124510","article-title":"Plasminogen activator inhibitor-1 antagonist TM5484 attenuates demyelination and axonal degeneration in a mice model of multiple sclerosis","volume":"10","author":"Pelisch","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2020.104872_bb0275","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrm2083","article-title":"Integrating cell-signalling pathways with NF-\u03baB and IKK function","volume":"8","author":"Perkins","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.nbd.2020.104872_bb0280","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12883-016-0784-z","article-title":"Looking beyond the brain to improve the pathogenic understanding of Parkinson\u2019s disease: implications of whole transcriptome profiling of Patients\u2019 skin","volume":"17","author":"Planken","year":"2017","journal-title":"BMC Neurol."},{"key":"10.1016\/j.nbd.2020.104872_bb0285","first-page":"3","article-title":"Human gene coexpression landscape: Confident network derived from tissue transcriptomic profiles","author":"Prieto","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2020.104872_bb0290","first-page":"9","article-title":"Systems-based analyses of brain regions functionally impacted in Parkinson\u2019s disease reveals underlying causal mechanisms","author":"Riley","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2020.104872_bb0295","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2017.1317577","article-title":"Analysis of extracellular RNA in cerebrospinal fluid","volume":"6","author":"Saugstad","year":"2017","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.nbd.2020.104872_bb0300","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/apha.12726","article-title":"Is plasminogen activator inhibitor-1 a physiological bottleneck bridging major depressive disorder and cardiovascular disease?","volume":"219","author":"Savoy","year":"2017","journal-title":"Acta Physiol."},{"key":"10.1016\/j.nbd.2020.104872_bb0305","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative Ct method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.nbd.2020.104872_bb0310","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/cne.24570","article-title":"Thyrotropin-releasing hormone (TRH) in the brain and pituitary of the teleost, Clarias batrachus and its role in regulation of hypophysiotropic dopamine neurons","volume":"527","author":"Singh","year":"2019","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.nbd.2020.104872_bb0315","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000332598","article-title":"Exon arrays reveal alternative splicing aberrations in Parkinson\u2019s disease leukocytes","volume":"10","author":"Soreq","year":"2012","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.nbd.2020.104872_bb0320","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1159\/000438701","article-title":"Advances in neurotrophic factor and cell-based therapies for Parkinson\u2019s disease: a mini-review","volume":"62","author":"Staudt","year":"2016","journal-title":"Gerontology"},{"key":"10.1016\/j.nbd.2020.104872_bb0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnana.2017.00029","article-title":"Glial cell line-derived neurotrophic factor gene delivery in Parkinson\u2019s disease: a delicate balance between neuroprotection, trophic effects, and unwanted compensatory mechanisms","volume":"11","author":"Tenenbaum","year":"2017","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.nbd.2020.104872_bb0330","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/bioinformatics\/btp120","article-title":"TopHat: discovering splice junctions with RNA-Seq","volume":"25","author":"Trapnell","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.nbd.2020.104872_bb0335","doi-asserted-by":"crossref","first-page":"113258","DOI":"10.18632\/oncotarget.19935","article-title":"Role of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in psychological stress and depression","volume":"8","author":"Tsai","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.nbd.2020.104872_bb0340","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.12688\/f1000research.15931.1","article-title":"FastQ screen: a tool for multi-genome mapping and quality control","volume":"7","author":"Wingett","year":"2018","journal-title":"F1000Research"},{"key":"10.1016\/j.nbd.2020.104872_bb0345","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1096\/fj.12-226555","article-title":"Neurotrophic factor expression in expandable cell populations from brain samples in living patients with Parkinson\u2019s disease","volume":"27","author":"Xu","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.nbd.2020.104872_bb0350","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-13-134","article-title":"Primer-BLAST\u202f: a tool to design target-specific primers for polymerase chain reaction","volume":"13","author":"Ye","year":"2012","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.nbd.2020.104872_bb0355","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s10072-016-2660-4","article-title":"Parkinson\u2019s disease and cerebrovascular disease: is there a link? A neurosonological case\u2013control study","volume":"37","author":"Zambito Marsala","year":"2016","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.nbd.2020.104872_bb0360","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2018.00485","article-title":"TRH analog, taltirelin protects dopaminergic neurons from neurotoxicity of MPTP and rotenone","author":"Zheng","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2020.104872_bb0365","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s13238-018-0599-3","article-title":"Transcriptional mechanism of IRF8 and PU.1 governs microglial activation in neurodegenerative condition","volume":"10","author":"Zhou","year":"2019","journal-title":"Protein Cell"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996120301479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996120301479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:21:32Z","timestamp":1760851292000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996120301479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":73,"alternative-id":["S0969996120301479"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2020.104872","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expanding the search for genetic biomarkers of Parkinson's disease into the living brain","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2020.104872","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104872"}}